We previously showed that 5-HT 2 receptor activation in the nucleus of the tractus solitarius (NTS) produced hypotension, bradycardia and facilitation of the baroreflex bradycardia.
Introduction
The arterial baroreceptor reflex is a critical mechanism for maintenance of circulatory homeostasis. However, different responses to stress need this reflex to be controlled. Indeed, the baroreflex cardiac response (bradycardia) is suppressed during "active" coping strategies such as the fight/flight defense reaction, when blood flow is redistributed to vascular beds thereby causing an increase in blood pressure (12, 22) . In contrast, hyporeactivity, sympathoinhibition, bradycardia and sometimes enhanced baroreflex bradycardia, occur during shock-like "passive" strategies observed after blood loss, deep pain or intense exercise (42, 5, 6, 1, 19, 3, 32) .
The preoptic area (POA) of the hypothalamus has been claimed to contribute to these "passive" coping strategies, because its activation produces behavioural relaxation (33) and depressive cardiovascular changes through its projection into the ventral part of the periaqueductal gray (vPAG) (15) , a region responsible for the production of "shock-like" responses to visceral pain (3) . In the forebrain, the infralimbic area (IL) of the medial prefrontal cortex, which is known to play a role in "moral emotions" (i.e. guilt and embarrassment, 34) could also potentially contribute to passive strategies. Indeed, i) IL sends massive projections to POA (8, 40) , ii) its stimulation in anaesthetized rats produces hypotension (38), and iii) IL may exert a tonic facilitatory influence on the baroreflex as shown by the reduction of the maximal cardiac response of this reflex after IL lesion in conscious rats (39, 28) .
The nucleus of the tractus solitarius (NTS) is the site of the first synapse of baroreceptor fiber afferent projections (24) . Several neurotransmitters in the NTS play a modulatory role in the central control of cardiovascular parameters. In particular, serotonin , through the stimulation of NTS 5-HT 2 receptors produces hypotension (18) and a vagus nerve-mediated bradycardia (20, 30, 27) . In addition, microinjections of 5-HT 2 receptor Page 3 of 41 3 agonists into the NTS were shown to facilitate the baroreflex bradycardia induced by phenylephrine administration (21) .
The aim of our study was to determine whether these NTS serotonin receptors were involved in the production of all the "passive coping-like" cardiovascular responses to IL or POA stimulation. Thus, as suggested by studies using awake rats, we first characterized, in pentobarbitone-anaesthetized rats, the hypotension, bradycardia and facilitation of the phenylephrine-or aortic depressor nerve-induced cardiac baroreflex bradycardia, produced by electrical and chemical (with D,L-homocysteic acid, DLH microinjections) stimulation of both IL or POA. Then, we investigated whether these responses were still present after microinjections, into the NTS, of ketanserin, a non-specific 5-HT 2 
Materials and Methods

General procedures
Experiments were performed on 152 male Sprague-Dawley rats, weighing 330-370 g.
Animals were kept under controlled environmental conditions (ambient temperature: 21±1°C, 60% relative humidity, food and water ad libitum, alternate 12 h: 12 h light/dark cycles) for at least one week after receipt from the breeding center (CER Janvier, Le Genest-St Isle, France Rats were anaesthetized with pentobarbitone (60 mg kg -1 , i.p.) and the depth of anaesthesia was regularly assessed by pinching a hindpaw and monitoring the stability of blood pressure and heart rate. In case of withdrawal reflex and/or variations of cardiovascular parameters, a supplementary dose of pentobarbitone was given (5-10 mg kg -1 i.v.). A cannula was inserted into the femoral vein for administration of drugs and/or additional doses of pentobarbitone. Systemic blood pressure (BP), mean blood pressure (MBP) and heart rate (HR) were monitored (Pressure Processor and DC Amplifier, Gould, Courtaboeuf, France) through a catheter inserted into the femoral artery. Electrocardiogram (ECG) was recorded using stainless steel pins placed subcutaneously into fore-and hindpaws; signals were amplified and filtered (Universal Amplifier, Gould). The R wave of ECG was discriminated with a window discriminator and used to generate pulses. Arterial blood pressure and ECG pulse signals were relayed to a 1401 interface (1401 Plus, CED, Cambridge, UK) connected to a computer running Spike 2 software (CED). Cardiac intervals and heart rate were automatically computed from R wave pulses (bin size: 1s). Rectal temperature was maintained at 37° C with a thermostatically controlled heating blanket. In most rats, the left aortic depressor nerve was dissected out from the vagus nerve by a lateral approach and placed on silver bipolar hook electrodes for electrical stimulation.
Procedures for IL or POA stimulation
Pentobarbitone-anaesthetized rats were placed in a stereotaxic frame with the head fixed in horizontal position. A craniotomy was performed, and a bipolar stimulating electrode or a single-barrel glass micropipette (<100 µm external diameter) connected to a Hamilton microsyringe were lowered into the left IL (P +2.5 to +3.2; L 0.3 to 0.8; V -4 to -5) or POA Page 5 of 41 5 (P: -1.0 to 0.5; L: 1.5 to 2; V: -6.5 to -7.5, in mm from bregma), using stereotaxic coordinates from Paxinos and Watson's atlas (25) . Both regions were identified by monitoring cardiovascular responses: a decrease in both mean blood pressure and heart rate, caused by local electrical stimulation (50 Hz, 1 ms pulse duration, 100 to 200 µA, 10 s) or microinjection of D, L-Homocysteic acid (0.3 M; 100 nl) through the glass micropipette.
Procedures for intra-NTS microinjections
The dorsal surface of the brainstem was exposed through a limited occipital craniotomy. A single-barrel glass micropipette was lowered into the NTS at predetermined coordinates for chemical inhibition and for microinjections of vehicles or 5-HT 2 receptor antagonists (0.4 mm rostral and lateral to the calamus scriptorius, and 0.4 mm beneath the dorsal surface of the medulla [21] ). The time interval between two symmetrical microinjections (100 nl) was less than 1 min. Intra-NTS microinjections of saline produced no changes in basal cardiovascular parameters and baroreflex bradycardia (31) . In the present study, we found that intra-NTS microinjections of MDL-100907 vehicle (dimethylsulfoxide, DMSO) affected neither basal heart rate (-5±3 bpm, n=8) and blood pressure (+4±1 mmHg, n=8), nor the cardiac response of the baroreflex (-70±4 bpm and -72±2 bpm before and after DMSO, respectively, n=8, ns).
Quantification of the cardiac baroreflex response
The baroreflex response was triggered by electrical stimulation of the aortic nerve (20 Hz, 1 ms, 50-100 µA). By adjusting the stimulation parameters, and following the preocedure described in Inui et al (14, 15) , bradycardic responses to stimulation of the aortic nerve were reduced to below the maximum response so that the putative facilitatory effects of IL or POA stimulation on the responses could be clearly demonstrated. In all cases, the cardiac reflex 
Quantification of the sympathetic baroreflex response
Since the hypotension induced by aortic depressor nerve stimulation is the combination of a sympathoinhibition (vasodilation) and a parasympathetic excitation (bradycardia) (17), we analysed the sympathetic reflex response during IL or POA stimulation in a group of rats (n=10) in which the bradycardic reflex component was suppressed by pretreatment with -methyl-atropine (30 µg/kg iv) (9) . On its own, -methyl-atropine produced an increase in heart rate (+53±5 bpm from a baseline of 365±5 bpm) that lasted for more than 30 min, but no significant changes in basal blood pressure (+3±1 mmHg from a baseline of 105±2 mmHg). Under this condition, the aortic-induced sympathetic response was defined as the maximal decrease in blood pressure ( MBP) observed during stimulation of the 7 aortic depressor nerve, expressed as a percentage of MBP baseline value in -methylatropine-pretreated rats.
Atenolol pretreatment
IL stimulation induces inhibition of the tonic sympathoexcitation of cardiac 1adrenergic receptors (38, 29) . To analyze the effect of IL (or POA) stimulation on the baroreflex bradycardia in the absence of any sympathetic influence on heart rate, another group of 10 rats was injected with atenolol (1 mg/kg i.v.), a specific antagonist at 1adrenoceptors.
Effects of IL or POA stimulation on the baroreflex responses
Aortic-induced baroreflex
The aortic depressor nerve was stimulated for 4 s while monitoring cardiovascular changes ("control"). Five min later, electrical or chemical stimulation of IL or POA was performed. In case of electrical stimulation of IL or POA, the aortic nerve was stimulated for 4 s precisely at the time when the cardiovascular changes evoked by cortical or hypothalamic stimulation (i.e. bradycardia and hypotension) were maximal ("experimental"). The effects of IL or POA stimulation on the baroreflex responses were calculated as the percent changes in "experimental" versus "control" conditions. In case of chemical stimulation of IL or POA, "experimental" baroreflex responses were determined 5 min after DLH microinjections, when cardiovascular modifications induced from both regions were maximal.
Phenylephrine-induced baroreflex
Phenylephrine (5 µg/kg, i.v.) was first administered ("control"). Ten minutes later, this treatment was repeated concomitantly with IL electrical stimulation ("experimental"). The Page 8 of 41 effects of IL stimulation on the baroreflex bradycardia were calculated as the percent changes in "experimental" versus "control" conditions.
Effects of IL or POA stimulation on the baroreflex responses after intra-NTS microinjections
In experiments aimed at analysing the effects of intra-NTS microinjections of various receptor ligands on IL-or POA-stimulation-induced facilitation of the baroreflex bradycardia, 3 successive determinations of the latter response were performed prior (10 min) to microinjections and considered stable if they differed from each other by less than 10 %.
Then, microinjections were performed and another determination of the baroreflex bradycardia facilitation was made 15 min later, to be compared with the 3 rd determination of the preceding series.
Histology
At the end of experiments, electrolytic lesions (50 Hz, 4 mA, 20 s) were made at central stimulation sites, and methylene blue (0.1 µl) was microinjected into the injection sites within the NTS. Rats were then perfused intracardially and brain coronal sections (60 µm) were cut and stained with neutral red. Methylene blue spread over a maximum of 0.2 mm from the injection site.
Statistical analyses
Absolute values are expressed as means ± S.E.M of n rats. Statistical comparisons between non pretreated rats and rats pretreated with either atenolol or -methyl-atropine, or subjected to intra-NTS microinjections, were made using a 2-way ANOVA followed by posthoc analysis (Bonferroni's test). In all other cases, Student's paired t-test was applied. The pH of all solutions microinjected into the NTS was adjusted to 7.4.
Results
Baseline values of MBP and HR in pentobarbitone-anaesthetized rats were 101±2 mmHg and 363±6 bpm, respectively (n=152). These responses were obtained only when DLH was microinjected at sites located between 2.7 and 3.0 mm rostrally to bregma (Fig 1 A) .
Effects of IL stimulation on the baroreflex cardiac response
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Electrical stimulation
Electrical stimulation of IL (n=35) at the same sites (Fig 1 A) as those found to be effective in chemical stimulation experiments also produced limited but significant decreases in heart rate (-24±2 bpm, p<0.05) and blood pressure (-17±1 mmHg, p<0.05). Both Table 1 ). Indeed, regression analysis of the linear part of this curve showed that the baroreflex gain was significantly increased during IL stimulation (p<0.05, Fig. 4 A) . Concomitant changes in cardiac interval paralleled those in heart rate (p<0.05 , Fig 4 B ). min after DLH administration, the bradycardic response to aortic nerve stimulation was significantly larger (+70%) than that measured prior to the treatment (-62±7 bpm from a Page 11 of 41 baseline of 365±10 bpm and -102±16 bpm from a baseline of 345±8 bpm, before and after DLH administration, respectively, p<0.05). This potentiation lasted approximately 10 minutes. It was observed only when DLH was microinjected at sites located at 0 to -0.5 mm caudally to bregma (Fig 1 B) .
Effects of POA stimulation on the baroreflex cardiac response
Electrical stimulation
Electrical (Fig 1 B) 
Effects of IL or POA stimulation on the baroreflex cardiac response in atenolol-pretreated rats
On its own, atenolol administration decreased heart rate (-40±5 bpm from a baseline of 359±6 bpm, n=10, p<0.05) for approximately one hour and half, and produced a small but not significant reduction of the aortic baroreflex bradycardia (-53±8 vs -66±7 bpm, n=10). In addition, administration of atenolol prevented the bradycardia normally observed during electrical stimulation of IL (-25±1 bpm vs -3±1 bpm before vs after atenolol, respectively, n=5, p<0.05) or POA (-35±2 bpm vs -7.0±3.2 bpm before vs after atenolol, respectively, n=5, p<0.05). However, the facilitation of the aortic-induced bradycardic response induced by both stimulations was of the same amplitude in atenolol-pretreated (+58 %, n=5, and +68 %, n=5, respectively), as in non-pretreated rats (+60% and +69%, respectively, see above).
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Effects of IL or POA stimulation on the sympathetic response in -methyl-atropine pretreated rats
Administration of -methyl-atropine (30 µg/kg i.v, n=10) totally blocked the aortic baroreflex parasympathetic bradycardia ( Fig 5) . In addition, the baroreflex decrease in blood pressure, which is due to both reflex sympathoinhibition and parasympathoactivation (see 17) , was significantly reduced in -methyl-atropine-pretreated rats (-21±1 mmHg and -13±1 mmHg, before and after -methyl-atropine, respectively, p<0.05, n=10). In the latter animals, the hypotensive aortic baroreflex response was not significantly changed when baroreflex was triggered during electrical stimulation of IL (-14±1 mmHg, n=5, Fig 5) or POA (-13±2 mmHg, n=5).
Effects of intra-NTS microinjections on IL stimulation-induced cardiovascular responses
After microinjections of saline (n=4) or DMSO (n=4) into the NTS at levels indicated in Fig 1 C , the effects of IL stimulation on baseline cardiovascular parameters and baroreflex cardiac response (see Table 2 ) were similar to those observed in naive non-injected rats (see above).
Microinjections of muscimol
Owens et al. (23) found that the hypotensive response to IL stimulation is abolished during NTS inhibition induced by local microinjection of muscimol, a specific GABA A receptor agonist. We herein noted that muscimol (50 pmol, n=4) microinjected at the level of the calamus scriptorius in the NTS (Fig 1, C1) , which produced increases in blood pressure (+15 %, p<0.05) and heart rate (+10 %, p<0.05) ( Table 2) , was able to prevent not only the hypotension but also the bradycardic response to IL stimulation ( Table 2 ). As expected from NTS inhibition by such local administration of muscimol, reflex bradycardia normally evoked by phenylephrine i.v. administration was completely suppressed in muscimol-pretreated rats Page 13 of 41 13 ([ HR/HR]/ MBP: -0.68±0.10 vs -0.05±0.01, before vs after intra-NTS muscimol, respectively, n=4, p<0.05).
Microinjections of 5-HT 2 receptor antagonists
Bilateral intra NTS microinjections of ketanserin (10 pmol) at predetermined sites (21) produced a short (1 min) non significant decrease in blood pressure (-8.1 mmHg, n=17) without affecting heart rate. Furthermore, ketanserin microinjections modified neither the aortic baroreflex response (-70±5 bpm and -75±4 bpm, before and after ketanserin, respectively, n=17), nor the hypotensive and bradycardic responses to IL stimulation (Table   2 ). However, after intra-NTS microinjections of ketanserin, IL stimulation no longer induced a potentiation of the aortic baroreflex bradycardia (n=13, Table 2 ). In the same manner, after ketanserin microinjections, IL stimulation was also unable to potentiate the phenylephrineevoked bradycardic response (+50 % and +5 %, before and after ketanserin pretreatment, respectively, n=4, P<0.05).
Microinjections of MDL-100907 (10 pmol, n=22) into the NTS (Fig 1, B2 ) produced no significant changes in basal heart rate (+5±3 bpm) and blood pressure (-2±3 mmHg), and did not affect the aortic baroreflex response (-71±5 bpm and -69±4 bpm, before and after MDL-100907 10 pmol, respectively). In addition, IL stimulation-induced hypotension and decrease in heart rate after MDL-100907 (10 pmol) microinjections were not different from those occurring in naive rats (Table 2 ). However, intra-NTS administration of MDL-100907 (n=12) dose-dependently prevented the expected potentiation of the aortic baroreflex bradycardia by IL stimulation (+50% and -5%, before and after MDL-100907, 10 pmol, respectively, n=6, P<0.05, Fig 6; +55% and +14% before and after MDL-100907, 5 pmol, respectively, n=6, p<0.05).This effect as well as that of ketaserin (Table 2 ) lasted at least 30 min.
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Effects of intra-NTS microinjections on POA stimulation-induced cardiovascular responses
Intra-NTS administration of saline (n=4) or DMSO (n=4) affected neither the decreases in basal heart rate (-32±3 bpm and -36±3 bpm, respectively) and blood pressure (-15±2 mmHg and -16±1 mmHg, respectively), nor the facilitation of the baroreflex bradycardia (+69 % and +68 %, respectively) produced by POA electrical stimulation (see above for the corresponding values in non-microinjected rats).
Microinjections of muscimol
Intra-NTS administration of muscimol (50 pmol, n=4) was found to prevent the hypotension (-15±2 mmHg and -2±1 mmHg, before and after muscimol, respectively, p<0.05) and the bradycardic response (-30±3 bpm and -5±2 bpm, before and after muscimol, respectively, <0.05) to POA stimulation.
Microinjections of MDL-100907
POA stimulation-induced hypotension (-15±4 mmHg, n=5) and decrease in heart rate (-37±5 bpm, n=5) after intra-NTS microinjection of MDL-100907 (10 pmol) were not different from those observed in naive rats (see above). However, the facilitation of the baroreflex bradycardia normally observed during POA stimulation was prevented by MDL-100907 (n=10) microinjections (+65% and -8%, before and after MDL-100907, 10 pmol, respectively, n=5, P<0.05, Fig 7; +68% and +17% before and after MDL-100907, 5 pmol, respectively, n=5, p<0.05).
Discussion
This study demonstrated that, in anaesthetized rats, stimulation of both the infralimbic cortex and the preoptic area in the hypothalamus potentiates the cardiac response of the baroreflex, and that NTS 5-HT 2A receptors are critically involved in this effect.
In conscious animals, chemical lesions of IL caused an inhibition of the baroreflex bradycardia (39, 28), suggesting that IL normally contributes to a tonic facilitatory control of this reflex response. Direct stimulation of IL in awake rats was found to induce cardiovascular changes similar to those associated with "active" coping strategies, i.e. increases in heart rate and blood pressure, which is in sharp contrast with that observed in anaesthetized rats (38) and conscious rabbits (2), associated with an inhibition of the baroreflex bradycardia (29) .
Thus comparison between anaesthetized and conscious rats suggests that a group of neurons involved in the defense reaction exists close to IL region, and exerts a predominant influence in unanesthetized rats. Because the main goal of our study was to analyze the role of the NTS 5-HT 2 receptors in the facilitation of the baroreflex bradycardia induced by IL or POA stimulation, such differences between conscious and anaesthetized rats led us to perform relevant experiments in anaesthetized rats, which exhibit no sign of the defense reaction during these stimulations. Thus, we found here that stimulation of both IL or POA was able to enhance the maximal aortic cardiac response of the baroreflex in anaesthetized rats. Similar results were obtained after electrical and chemical stimulation, allowing the conclusion that local cells but not fibers "en passage" were involved in the observed effect. In addition, IL stimulation produced an increase of the slope of baroreflex sensitivity curve (expressed as changes of either heart rate or cardiac interval) evoked by phenylephrine administration, indicating not only the maximal cardiac reflex response but also the sensitivity of this reflex were enhanced by such stimulation. Interestingly, intravenous administration of atenolol did not affect the potentiation of the baroreflex bradycardia observed during IL or POA stimulation, showing that this effect occurred independently of the cardiac sympathoinhibition triggered by these stimulations.
Concerning the sympathetic component of the baroreflex, previous studies in vagotomized rats (in which the parasympathetic component is inactivated) showed that POA stimulation produced a slight facilitation of the residual reflex hypotension (15) . However, in our studies, in -methyl-atropine pretreated rats, IL or POA stimulation was unable to produce any facilitatory influence on the residual reflex hypotension.
Previous studies suggested that the NTS could be involved in IL-induced cardiovascular changes. It has notably been shown that IL sent direct projections to the NTS (36) and that the hypotensive responses to IL stimulation are suppressed by chemical inhibition of the NTS (10, 23) . In addition, clear-cut data showed that the caudal part of the nucleus raphe magnus, which is known to send serotonergic projections to the NTS (35), is involved in all the cardiovascular changes induced by POA and vPAG stimulation (14, 15) .
Here, we found that both hypotensive and bradycardic responses to IL or POA stimulation were abolished by chemical inhibition of the NTS, confirming the key role of this nucleus in these effects. However, whether NTS cells are activated directly by IL or POA or via the stimulation of the nucleus raphe magnus, to produce these responses, is still an unsolved question.
It has previously been established that microinjection of 5-HT 2 receptor agonists into the NTS induces hypotension and bradycardia (20, 27) , and that local administration of subthreshold doses only of such ligands can potentiate the cardiac response of the baroreflex (21) . Therefore, it could be hypothesized that NTS 5-HT 2 receptors are key components in the hypotension, bradycardia and enhanced cardiac baroreflex response occurring during IL or POA stimulation. Actually, we found that intra-NTS microinjections of ketanserin, a potent 5-HT 2 receptor antagonist, was able to prevent the facilitation of the cardiac response of the baroreflex but not the hypotension and bradycardia induced by IL stimulation. Thus, NTS 5-Page 17 of 41 HT 2 receptors appear to be involved in the facilitation of the baroreflex bradycardia only.
Ketanserin has high affinity for 5-HT 2A (pKi= 8.9) and 5-HT 2C (pKi= 7.0) receptors, and lower affinity for 5-HT 2B receptors [pKi=5.4] (26), which suggests that 5-HT 2A/2C receptors possibly mediated the facilitatory effect of IL stimulation on the baroreflex bradycardia. Like that found with ketanserin, intra-NTS microinjections of MDL-100907, a selective 5-HT 2A receptor antagonist (16) , also prevented the facilitation of the reflex bradycardia but not the decrease in blood pressure and heart rate induced by IL stimulation. In addition, MDL-100907, which did not affect POA-induced changes in basal heart rate and blood pressure, also suppressed the facilitation of the cardiac response of the baroreflex normally evoked by POA activation. Altogether, these results show that the NTS is involved in IL-or POAstimulation-induced hypotensive and bradycardic responses, and that the facilitation of the baroreflex bradycardia produced by IL or POA stimulation is mediated by NTS 5-HT 2A receptor activation. The latter effect might be causally related to 5-HT 2A receptor-mediated partial depolarization of the cell membrane, which is known to promote N-methyl-D-aspartate (NMDA) receptor activation, at the origin of baroreflex signaling within the NTS (7) . In line with this idea, it is well established that excitatory amino acid synaptic transmission through NMDA receptors requires prior cell membrane depolarization (11) , and that 5-HT 2A and NMDA receptors are colocalized in some neurons within the NTS (13) .
We previously found that the defense reaction involves NTS 5-HT 3 receptors to produce inhibition of the baroreflex bradycardia (31) . It thus appears that serotonergic fibers, probably originating from different raphe nuclei or different subareas within the raphe magnus, can modulate the baroreflex cardiac response in opposite ways during "active" and "passive" coping strategies. On the one hand, some fibers would target NTS cells endowed with 5-HT 3 receptors, which activation produces the inhibition of the baroreflex bradycardia Previous studies (14, 15, 22) 
